Biomarkers Europe 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
Monte Rosa Therapeutics at Biomarkers Europe 2026
Oct 13–14, 2026 Basel, Switzerland ~1k attendees Website
Monte Rosa Therapeutics takes part in 2 sessions at Biomarkers Europe 2026 in Basel. Its sessions cover moving biomarkers from discovery into clinical use. One looks at which kinds of biomarkers help in the early development of molecular glue degraders, drugs that make cells break down disease-causing proteins, for cancer and immune diseases.
| Organization | Biomarkers Europe 2026 Attendance |
|---|---|
Monte Rosa Therapeutics Boston, MA | |
Develops molecular glue degrader drugs that direct the cell's protein disposal machinery against targets in oncology and immunology. | Talk Tue Oct 13 12:40pm–1:05pm Biomarker Modalities In Early Development Of Molecular Glue Degraders For Oncology And Immune-Mediated Diseases Biomarker discovery & translation Panel Tue Oct 13 1:05pm–1:30pm Translating Biomarkers From Discovery To Clinical Use Biomarker discovery & translation |
Instantly find 20 buyers from Monte Rosa Therapeutics
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Biomarkers, CDx & Precision Medicine or its organizers. Submit a correction